SPERO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Spero Therapeutics, Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - June 1, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Spero Therapeutics, Inc. ("Spero" or the "Company") (NASDAQ: SPRO).
To view an enhanced version of this graphic, please visit:
If you invested in Spero stock and would like to discuss your legal rights, click here: www.faruqilaw.com/SPRO. There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com.
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292 or (212) 983-9330
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/56932